Histology and Cytology Market Industry Size, Share, Forecast 2026

Summary
Table Of Content

Market Synopsis

The histology and cytology market is expected to grow at a compound annual growth rate (CAGR) of 13.6% from 2018 to 2026, from US$ 8,928.1 million in 2017 to US$ 27,949.9 million by 2026. As per the research citations provided by the World Health Organization (WHO), the global burden of cancer is approximately 18.1 million new cases and 9.6 million deaths in 2018.

The major factors responsible for the occurrence of chronic disease are increased consumption of tobacco, alcohol, and junk food, a sedentary lifestyle, and stress. Researchers are of the view that, in the era of modern technology, the utilization of sophisticated technology pertaining to histology and cytology examinations will help in promoting early diagnosis and curtailing morbidity associated with chronic ailments. Rising public health awareness will support the growth of the histology and cytology markets from 2018 to 2026.

Increasing demand for cell screening and inherent features such as low cost, high sensitivity, and adequate specificity drive the cytology examination market’s growth.

Cytology examinations dominate the type of examination segment in the histology and cytology market. Increased demand for cell screening in breast and cervical cancer patients is one of the growth factors driving the cytology examination market. Inherent features such as low cost, high sensitivity, and adequate specificity associated with the cytology examination procedure further fortify its market growth.

Histology examination procedures will be growing at a rapid pace on account of technological advancement in tissue diagnostic kits and strategic collaboration among major players for the further development and commercialization of histology examination procedures in the diagnosis of chronic ailments.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

In North America, market growth is being driven by an increase in cancer diagnoses and increased public health awareness.

North America currently holds 35% of the market and is the leading regional market for histology and cytology. The major factors controlling its market growth are the significant rise in cancer diagnosis and increasing public health awareness. As per the statistics provided by the Centers for Disease Control and Prevention (CDC) in 2017, the number of adults diagnosed with cancer was 23.2 million, which represents 9.4% of the total population. The existence of key players such as Abbott Laboratories, Inc., Hologic, Inc., Thermo Fisher Scientific, Inc., etc., provides a positive impetus to the histology and cytology market growth in the North American region.

On account of the rising prevalence of cancer and the supportive environment provided by the European Medical Agency (EMA), Europe holds 30% of the market share for histology and cytology diagnostic procedures. Asia Pacific is accountable for 16% of the market share and is keen to register outstanding growth owing to rampant growth in healthcare infrastructure development and the adoption of sophisticated diagnostic technology pertaining to cytology and histology studies.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respectivesegments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by type of examination and by geography.

Biotechnology companies specializing in the histology and cytology market are Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Trivitron Healthcare, Hologic, Inc., Koninklijke Philips N.V., and Life Technologies Corporation.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key questions are answered in this report.

Which biotechnology companies are engaged in the development of histology and cytology examination technology?
What is the global prevalence rate of life-threatening chronic ailments?
Which strategic collaborations and mergers among major players will promote the histology and cytology market’s growth?
Which factors are responsible for the manifestation of cancer?
Why is the cytology examination procedure more popular in comparison to the histology examination procedure?
Why are North America and Europe responsible for the major market share in the regional segment of the histology and cytology market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Type of Examination
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global HC Market Portraiture
2.2. Global HC Market, by Type of Examination, 2017 (US$ Mn)
2.3. Global HC Market, by Geography, 2017 (US$ Mn)

Chapter 3. Histology and Cytology (HC) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global HC Market, by Key Players, 2017

Chapter 4. Global Histology and Cytology (HC) Market, by Type of Examination
4.1. Overview
4.2. Cytology
4.2.1. Cervical Cancer
4.2.2. Breast Cancer
4.2.3. Other Cancers
4.3. Histology

Chapter 5. Global Histology and Cytology (HC) Market, by Geography
5.1. Overview
5.2. North America HC Market Analysis, 2016 – 2026
5.2.1. North America HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
5.2.2. North America HC Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe HC Market Analysis, 2016 – 2026
5.3.1. Europe HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
5.3.2. Europe HC Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific HC Market Analysis, 2016 – 2026
5.4.1. Asia Pacific HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific HC Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America HC Market Analysis, 2016 – 2026
5.5.1. Latin America HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
5.5.2. Latin America HC Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa HC Market Analysis, 2016 – 2026
5.6.1. MEA HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
5.6.2. MEA HC Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Becton Dickinson and Company
6.3. Danaher Corporation
6.4. F.Hoffman-La Roche Ltd.
6.5. Hologic, Inc.
6.6. Koninklijke Philips N.V.
6.7. Life Technologies Corporation
6.8. Sysmex Corporation
6.9. Thermo Fisher Scientific, Inc.
6.10. Trivitron Healthcare

List of Figures

FIG. 1 Histology and Cytology (HC) Market: Research Methodology
FIG. 2 HC: Market Segmentation
FIG. 3 Global HC Market, by Type of Examination, 2017 (US$ Mn)
FIG. 4 Global HC Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global HC Market, by Key Players, 2017
FIG. 7 Global Cervical Cancer Market for HC, 2016 – 2026 (US$ Mn)
FIG. 8 Global Breast Cancer Market for HC, 2016 – 2026 (US$ Mn)
FIG. 9 Global Other Cancers Market for HC, 2016 – 2026 (US$ Mn)
FIG. 10 Global Histology Market, 2016 – 2026 (US$ Mn)
FIG. 11 U.S. HC Market, 2016 – 2026 (US$ Mn)
FIG. 12 Canada HC Market, 2016 – 2026 (US$ Mn)
FIG. 13 U.K. HC Market, 2016 – 2026 (US$ Mn)
FIG. 14 Germany HC Market, 2016 – 2026 (US$ Mn)
FIG. 15 Rest of Europe HC Market, 2016 – 2026 (US$ Mn)
FIG. 16 China HC Market, 2016 – 2026 (US$ Mn)
FIG. 17 Japan HC Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Asia Pacific HC Market, 2016 – 2026 (US$ Mn)
FIG. 19 Brazil HC Market, 2016 – 2026 (US$ Mn)
FIG. 20 Mexico HC Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Latin America HC Market, 2016 – 2026 (US$ Mn)
FIG. 22 GCC HC Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Middle East and Africa HC Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Histology and Cytology (HC) Market Portraiture
TABLE 2 Global HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
TABLE 3 Global Cytology Market, 2016 – 2026 (US$ Mn)
TABLE 4 Global HC Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
TABLE 6 North America HC Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
TABLE 8 Europe HC Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific HC Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America HC Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa HC Market, by Type of Examination, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa HC Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 15 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 F.Hoffman-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Hologic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Koninklijke Philips N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Life Technologies Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Trivitron Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Question

What is the size of Histology and Cytology Market?

The market for Histology and Cytology Market is expected to reach USD$ 27,949.9 Mn in 2026.

What is the Histology and Cytology Market CAGR?

The Histology and Cytology Market is expected to see significant CAGR growth over the coming years, at 13.6%.

What is the Forecast period considered for Histology and Cytology Market?

The report is forecasted from 2018 -2026.

What is the base year considered for Histology and Cytology Market?

The base year of this report is 2017.

Who are the major players in this market?

Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F. Hoffmann-La Roche Ltd . are some of the major players in the global market.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –